Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development... see more

Recent & Breaking News (NDAQ:SLP)

U.S. FDA Renews DILIsym® Software Licenses for 7th Year

Business Wire April 4, 2024

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Business Wire April 3, 2024

Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

Business Wire March 20, 2024

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Business Wire March 13, 2024

Simulations Plus and the University of Bath Awarded New FDA Grant

Business Wire March 5, 2024

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

Business Wire February 15, 2024

Simulations Plus Launches Corporate Development Initiative

Business Wire February 13, 2024

Simulations Plus to Participate in Upcoming Healthcare Conferences

Business Wire February 6, 2024

Simulations Plus Releases GastroPlus® Version 9.9

Business Wire January 30, 2024

Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant

Business Wire January 9, 2024

Simulations Plus Reports First Quarter Fiscal 2024 Financial Results

Business Wire January 3, 2024

Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

Business Wire January 3, 2024

Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

Business Wire December 20, 2023

Simulations Plus Outlines Paths to Win at 2023 Investor Day

Business Wire November 14, 2023

ISoP New Board of Trustees Members Announced

Business Wire November 8, 2023

Simulations Plus to Host Investor Day on Tuesday, November 14th

Business Wire October 31, 2023

Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results

Business Wire October 25, 2023

Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Business Wire October 11, 2023

Simulations Plus Receives New FDA Grant Award

Business Wire September 21, 2023

Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors

Business Wire September 7, 2023